Curriculum Vitae
Yasuharu Kashiwagura, Ph. D.
Associate professor
Bussiness Address: Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences,
University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan
E-mail: kashiwagura@u-shizuoka-ken.ac.jp
Phone/Fax: +81-54-264-5234

1. Birth
July 15, 1977

2. Education
B.Sc. in Pharmacy, Showa University, 2002
M.Sc. in Pharmacy, Showa University, 2004
Ph.D. in Pharmacy, University of Shizuoka, 2014

3. Woek Experience
2004.4–2014.8

Kameda Medical Center Hospital(Clinical Pharmacist, Department of Pharmacy)2014.9–2023.3

University of Shizuoka(Assistant Professor, School of Pharmaceutical Sciences, Department of Pharmacy
Practice & Science)

2023.4–present University of Shizuoka(Associate Professor, School of Pharmaceutical Sciences, Department of Pharmacy
Practice & Science)

4. Recent Publications
1.

Kashiwagura Y, Takusagawa S, Ikematsu Y, Tanaka S, Namiki N, Uchida S, Tablet
characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10
granules prepared by different methods. Acta Pharmaceutica, 73, 107-119, 2023

2.

Nagata E, Kashiwagura Y, Okada E, Tanaka S, Sano S, Nishida M, Hayano S, Iwashima S,Hakamata A, Odagiri K, Inui N, Watanabe H, Umemura K, Uchida S, Efficacy and Safety ofPropranolol Cream in Infantile Hemangioma: A Prospective Pilot Study. J Pharmacol Sci, 149,60-65, 2022

3.

Kashiwagura Y, Hakamata A, Shirai M, Endoh A, Tanaka S, Inui N, Watanabe H, Namiki N,Uchida S, Topical formulations of propranolol for infantile hemangiomas: characteristics offormulations and three cases of infants administered topical propranolol cream. Chem PharmBull, 70, 277-282, 2022

4.

Umemoto Y, Tanaka S, Kambayashi A, Sugimoto K, Kashiwagura Y, Namiki N, Uchida S,Gummi Formulations Comprising Amenamevir Solid Dispersions with Polyvinyl Alcohol.
Chem Pharm Bull, 69, 862-871, 2021

5.

Oshiro-Sembokuya M, Uchida S, Kashiwagura Y, Ashihara M, Tanaka S, Hashimoto T,
Kokubu C, Namiki N, Evaluation of Disappearance Time and Palatability of Foams in the Oral
Cavities of Healthy Volunteers, and Preparation of Drug-Containing Foam Formulations forUse in the Treatment of Oral Mucositis. Chem Pharm Bull, 69, 400-406, 2021

6.

Kashiwagura Y, Uchida S, Hakamata A, Watanabe H, Namiki N, In vitro transdermal
permeation and in vivo transdermal absorption of domperidone cream formulations
compounded from tablets as a hospital formulation. Pharmazie, 76, 2-5, 2021

7.

Suzuki H, Uchida S, Kashiwagura Y, Tanaka S, Yamauchi K, Kageyama S, Namiki N, Impactof community pharmacist-led intensive education on the control of serum phosphate levels in
hemodialysis patients. Int J Clin Pharm, 43, 220-228, 2021

8.

Imoto J, Uchida S, Kashiwagura Y, Tanaka S, Namiki N, Morphological evaluation of lowdose midazolam granules by laser Raman microscopy. Int J Pharm, 590, 119940, 2020

9.

Tanaka S, Uchida S, Sotoyama M, Kashiwagura Y, Namiki N, Combining powder
formulations of drugs with food and beverages to improve palatability. Biol Pharm Bull, 43,1954-1959, 2020

10. Kurashima H, Uchida S, Kashiwagura Y, Tanaka S, Namiki N, Evaluation of Weight
Variation in Mini-Tablets Manufactured by a Multiple-Tip Tool. Chem Pharm Bull, 68, 981988, 2020
11. Umemoto Y, Uchida S, Yoshida T, Shimada K, Kojima H, Takagi A, Tanaka S, Kashiwagura
Y, Namiki N, An effective polyvinyl alcohol for the solubilization of poorly water-soluble
drugs in solid dispersion formulations. Int J Clin Pharmacol Ther, 55, 101401, 201912. Yoshida M, Uchida S, Kashiwagura Y, Tanaka S, Matsui R, Namiki N, Evaluation of in Vitro
and in Vivo Transdermal Absorption of Solifenacin Succinate. Chem Pharm Bull, 67, 12251231, 201913. Sotoyama M, Uchida S, Kamiya C, Tanaka S, Kashiwagura Y, Hakamata A, Odagiri K, InuiN, Watanabe H, Namiki N, Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating
Mitiglinide/Voglibose Tablets. Chem Pharm Bull, 67, 540-545, 2019
14. Takano H, Uchida S, Kashiwagura Y, Tanaka S, Hakamata A, Odagiri K, Inui N, Watanabe H,Namiki N, Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets ofRebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability. Chem PharmBull, 67, 112-119, 2019
15. Katayama T, Uchida S, Kamiya C, Tanaka S, Kashiwagura Y, Hakamata A, Odagiri K, InuiN, Watanabe H, Namiki N, In Vivo Drug Dissolution in Human Oral Cavity from Orally
Disintegrating Tablet and Comparability with in Vitro Testing. Chem Pharm Bull, 66, 9991005, 201816. Yasumuro O, Uchida S, Kashiwagura Y, Suzuki A, Tanaka S, Inui N, Watanabe H, Namiki N,
Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels
following oral administration of omeprazole and vonoprazan in rats. Xenobiotica, 48, 11061112, 2018